Search research articles
Contact Us
Filters
Showing results (591-600 of 743) with videos related to
Page
of 75
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
April 1, 1994
[Renal nephrogenic nephroma: an little known exceptional tumor. Apropos of a case disclosed by xanthogranulomatous pyelonephritis]
N Mottet, F Dagues, C Pignodel, et al.
Actas Urologicas Espanolas
|
July 16, 2011
[EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer]
N Mottet, J Bellmunt, M Bolla, et al.
Neuroimmunomodulation
|
January 21, 2012
Expression of the growth hormone/insulin-like growth factor axis during Balb/c thymus ontogeny and effects of growth hormone upon ex vivo T cell differentiation
Hamid Kermani, Lindsay Goffinet, Marie Mottet, et al.
Biomicrofluidics
|
October 30, 2014
A three dimensional thermoplastic microfluidic chip for robust cell capture and high resolution imaging
Guillaume Mottet, Karla Perez-Toralla, Ezgi Tulukcuoglu, et al.
Frontiers in Endocrinology
|
December 19, 2022
Low number of neurosecretory vesicles in neuroblastoma impairs massive catecholamine release and prevents hypertension
Annick Mühlethaler-Mottet, Silvia Uccella, Deborah Marchiori, et al.
BMC Cancer
|
October 12, 2016
Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma
Marjorie Flahaut, Nicolas Jauquier, Nadja Chevalier, et al.
Aging
|
July 13, 2021
HDAC2 and 7 down-regulation induces senescence in dermal fibroblasts
Céline Warnon, Karim Bouhjar, Noëlle Ninane, et al.
European Urology
|
November 9, 2010
EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease
Axel Heidenreich, Joaquim Bellmunt, Michel Bolla, et al.
European Urology
|
February 15, 2011
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer
Nicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al.
Digestion
|
August 29, 2019
Therapeutic Drug Monitoring to Guide Clinical Decision Making in Inflammatory Bowel Disease Patients with Loss of Response to Anti-TNF: A Delphi Technique-Based Consensus
Thomas Greuter, Michel H Maillard, Pascal Juillerat, et al.
Page
of 75
Search research articles
Search
Showing results (591-600 of 743) with videos related to
Sort By:
Page
of 75
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
April 1, 1994
[Renal nephrogenic nephroma: an little known exceptional tumor. Apropos of a case disclosed by xanthogranulomatous pyelonephritis]
N Mottet, F Dagues, C Pignodel, et al.
Actas Urologicas Espanolas
|
July 16, 2011
[EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer]
N Mottet, J Bellmunt, M Bolla, et al.
Neuroimmunomodulation
|
January 21, 2012
Expression of the growth hormone/insulin-like growth factor axis during Balb/c thymus ontogeny and effects of growth hormone upon ex vivo T cell differentiation
Hamid Kermani, Lindsay Goffinet, Marie Mottet, et al.
Biomicrofluidics
|
October 30, 2014
A three dimensional thermoplastic microfluidic chip for robust cell capture and high resolution imaging
Guillaume Mottet, Karla Perez-Toralla, Ezgi Tulukcuoglu, et al.
Frontiers in Endocrinology
|
December 19, 2022
Low number of neurosecretory vesicles in neuroblastoma impairs massive catecholamine release and prevents hypertension
Annick Mühlethaler-Mottet, Silvia Uccella, Deborah Marchiori, et al.
BMC Cancer
|
October 12, 2016
Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma
Marjorie Flahaut, Nicolas Jauquier, Nadja Chevalier, et al.
Aging
|
July 13, 2021
HDAC2 and 7 down-regulation induces senescence in dermal fibroblasts
Céline Warnon, Karim Bouhjar, Noëlle Ninane, et al.
European Urology
|
November 9, 2010
EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease
Axel Heidenreich, Joaquim Bellmunt, Michel Bolla, et al.
European Urology
|
February 15, 2011
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer
Nicolas Mottet, Joaquim Bellmunt, Michel Bolla, et al.
Digestion
|
August 29, 2019
Therapeutic Drug Monitoring to Guide Clinical Decision Making in Inflammatory Bowel Disease Patients with Loss of Response to Anti-TNF: A Delphi Technique-Based Consensus
Thomas Greuter, Michel H Maillard, Pascal Juillerat, et al.
Page
of 75